🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSELECT cost-effectiveness — looking for input Page 6

SELECT cost-effectiveness — looking for input

claudia_zurich Tue, Nov 11, 2025 at 1:22 PM 36 replies 1,506 viewsPage 6 of 8
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Dec 4, 2025 at 9:19 PM#26
Dr.NateNeph said:
TinaHashiRN said: ...cardiovascular risk is just another fad...

Metabolic syndrome resolution on cardiovascular risk: I went from meeting 5 of 5 diagnostic criteria to meeting ZERO after 10 months of treatment.

The 5 criteria (and my journey):

  1. Waist circumference: 49" → 35" ✅ Resolved
  2. Triglycerides: 221 → 106 ✅ Resolved
  3. HDL: 33 → 53 ✅ Resolved
  4. Blood pressure: 141/91 → 119/73 ✅ Resolved
  5. Fasting glucose: 116 → 85 ✅ Resolved

Metabolic syndrome reversal is, in my view, the most medically significant outcome of GLP-1 therapy.

Last edited: Dec 4, 2025 at 11:19 PM
39 14labquiet_amy, emily_PDX, Dr.SleepRoch and 36 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Dec 7, 2025 at 2:54 AM#27
Dr.NateNeph said:
TinaHashiRN said: ...cardiovascular risk is just another fad...

Senior perspective on cardiovascular risk: I'm 66 years old and started this journey skeptically. My cardiologist recommended it after years of failed interventions.

10 months later: down 49 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

38 13roxy_nash, tony_orlando, Dr.NephBHM_UK and 35 others
Reply Quote Save Share Report
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Dec 9, 2025 at 8:30 AM#28
Dr.NateNeph said:
TinaHashiRN said: ...cardiovascular risk is just another fad...

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Sending this to two other people who asked me the same thing last week.

37 12PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 34 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Dec 11, 2025 at 2:07 PM#29

From the other side of the consultation, briefly.

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

Last edited: Dec 11, 2025 at 7:07 PM
36 11anders_CPH, Dr.NutriCornell, pam_stl and 33 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Dec 13, 2025 at 7:46 PM#30

Closing the loop on my own question.

Update: approved on the third attempt after a peer-to-peer. Nothing about my case changed; only who was doing the talking.

14 14kevin_tulsa, Dr.PainCLE, mike_mealprep and 11 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register